AAAAAA

   
Results: 1-12 |
Results: 12
ADENOCARCINOMA OF ESOPHAGUS JUNCTION AND CARDIA - SIMILAR RESPONSE TONEOADJUVANT THERAPY
Authors: MULLIGAN ED DUNNE B PURCELL T GRIFFIN M NOONAN N HOLLYWOOD D KEELING N REYNOLDS JV HENNESSY TPJ
Citation: Ed. Mulligan et al., ADENOCARCINOMA OF ESOPHAGUS JUNCTION AND CARDIA - SIMILAR RESPONSE TONEOADJUVANT THERAPY, Gastroenterology, 114(4), 1998, pp. 2673-2673
ADJUNCTIVE CHEMORADIOTHERAPY IN ESOPHAGEAL-CARCINOMA DOES NOT INCREASE POSTOPERATIVE MORBIDITY OR MORTALITY
Authors: MULLIGAN ED DUNNE B PURCELL T GRIFFIN M NOONAN N HOLLYWOOD D KEELING N REYNOLDS JV HENNESSY TPJ
Citation: Ed. Mulligan et al., ADJUNCTIVE CHEMORADIOTHERAPY IN ESOPHAGEAL-CARCINOMA DOES NOT INCREASE POSTOPERATIVE MORBIDITY OR MORTALITY, Gastroenterology, 114(4), 1998, pp. 2674-2674
CLINICOPATHOLOGICAL FACTORS IN THE RESPONSE TO NEOADJUVANT CHEMORADIOTHERAPY IN ESOPHAGEAL ADENOCARCINOMA
Authors: MULLIGAN ED DUNNE B PURCELL T GRIFFIN M NOONAN N HOLLYWOOD D KEELING N REYNOLDS JV HENNESSY TPJ
Citation: Ed. Mulligan et al., CLINICOPATHOLOGICAL FACTORS IN THE RESPONSE TO NEOADJUVANT CHEMORADIOTHERAPY IN ESOPHAGEAL ADENOCARCINOMA, Gastroenterology, 114(4), 1998, pp. 2675-2675
THE IMPORTANCE OF NEGATIVE MICROSCOPY MARGINS IN THE MULTIMODALITY THERAPY OF ESOPHAGEAL CANCER
Authors: MULLIGAN ED DUNNE B PURCELL T GRIFFIN M NOONAN N HOLLYWOOD D KEELING N REYNOLDS JV HENNESSY TPJ
Citation: Ed. Mulligan et al., THE IMPORTANCE OF NEGATIVE MICROSCOPY MARGINS IN THE MULTIMODALITY THERAPY OF ESOPHAGEAL CANCER, Gastroenterology, 114(4), 1998, pp. 2676-2676
IMPORTANCE OF NEGATIVE MICROSCOPIC MARGINS IN THE MULTIMODALITY THERAPY OF ESOPHAGEAL CANCER
Authors: MULLIGAN ED WALSH TN DUNNE B PURCELL T GRIFFIN M NOONAN N HOLLYWOOD D KEELING N REYNOLDS JV HENNESSY TPJ
Citation: Ed. Mulligan et al., IMPORTANCE OF NEGATIVE MICROSCOPIC MARGINS IN THE MULTIMODALITY THERAPY OF ESOPHAGEAL CANCER, British Journal of Surgery, 85(5), 1998, pp. 695-695
TUMOR LENGTH PREDICTS RESPONSE TO NEOADJUVANT CHEMORADIOTHERAPY IN ESOPHAGEAL ADENOCARCINOMA
Authors: MULLIGAN ED WALSH TN DUNNE B PURCELL T GRIFFIN M NOONAN N HOLLYWOOD D KEELING N REYNOLDS JV HENNESSY TPJ
Citation: Ed. Mulligan et al., TUMOR LENGTH PREDICTS RESPONSE TO NEOADJUVANT CHEMORADIOTHERAPY IN ESOPHAGEAL ADENOCARCINOMA, British Journal of Surgery, 85(5), 1998, pp. 696-696
ADJUNCTIVE CHEMORADIOTHERAPY IN ESOPHAGEAL-CARCINOMA - NO INCREASE INPOSTOPERATIVE MORBIDITY OR MORTALITY
Authors: MULLIGAN ED PURCELL T DUNNE B GRIFFIN M NOONAN N HOLLYWOOD D KEELING N REYNOLDS JV HENNESSY TPJ
Citation: Ed. Mulligan et al., ADJUNCTIVE CHEMORADIOTHERAPY IN ESOPHAGEAL-CARCINOMA - NO INCREASE INPOSTOPERATIVE MORBIDITY OR MORTALITY, British Journal of Surgery, 85, 1998, pp. 29-29
ADENOCARCINOMA OF ESOPHAGUS JUNCTION AND CARDIA - SIMILAR RESPONSE TONEOADJUVANT THERAPY
Authors: MULLIGAN ED PURCELL T DUNNE B GRIFFIN M NOONAN N HOLLYWOOD D KEELING N REYNOLDS JV HENNESSY TPJ
Citation: Ed. Mulligan et al., ADENOCARCINOMA OF ESOPHAGUS JUNCTION AND CARDIA - SIMILAR RESPONSE TONEOADJUVANT THERAPY, British Journal of Surgery, 85, 1998, pp. 86-86
USE OF TRIPLE HELIX-FORMING OLIGODEOXYNUCLEOTIDES AS A NOVEL THERAPEUTIC STRATEGY FOR ERB-B2 POSITIVE BREAST-CANCER
Authors: DOLAN C WOGAN A HOLLYWOOD D MCCANN SR LAWLER M
Citation: C. Dolan et al., USE OF TRIPLE HELIX-FORMING OLIGODEOXYNUCLEOTIDES AS A NOVEL THERAPEUTIC STRATEGY FOR ERB-B2 POSITIVE BREAST-CANCER, British Journal of Cancer, 78, 1998, pp. 28-28
A COMPARISON OF MULTIMODAL THERAPY AND SURGERY FOR ESOPHAGEAL ADENOCARCINOMA
Authors: WALSH TN NOONAN N HOLLYWOOD D KELLY A KEELING N HENNESSY TPJ
Citation: Tn. Walsh et al., A COMPARISON OF MULTIMODAL THERAPY AND SURGERY FOR ESOPHAGEAL ADENOCARCINOMA, The New England journal of medicine, 335(7), 1996, pp. 462-467
MULTIMODALITY THERAPY VERSUS SURGERY FOR ESOPHAGEAL ADENOCARCINOMA - A PROSPECTIVE RANDOMIZED TRIAL
Authors: WALSH TN NOONAN N HOLLYWOOD D KELLY A KEELING PNW HENNESSY TPJ
Citation: Tn. Walsh et al., MULTIMODALITY THERAPY VERSUS SURGERY FOR ESOPHAGEAL ADENOCARCINOMA - A PROSPECTIVE RANDOMIZED TRIAL, Gastroenterology, 110(4), 1996, pp. 611-611
MULTIMODALITY TREATMENT PLUS SURGERY VERSUS SURGERY ALONE FOR ESOPHAGEAL ADENOCARCINOMA
Authors: WALSH TN NOONAN N HOLLYWOOD D KEELING PWN HENNESSY TPJ
Citation: Tn. Walsh et al., MULTIMODALITY TREATMENT PLUS SURGERY VERSUS SURGERY ALONE FOR ESOPHAGEAL ADENOCARCINOMA, Gastroenterology, 108(4), 1995, pp. 550-550
Risultati: 1-12 |